Our Recommendations
- Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection (2016)
- Guidelines: updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring (2021)
- Updated Recommendations Onservice Delivery For The Treatment And Care Of People Living With HIV. Summary Slides (2021)
- Consolidated HIV guidelines for prevention, treatment, service delivery & monitoring (2021)
New Publications
- Malawi Country Operational Plan 2021 Strategic Direction Summary May 19, 2021 (2021)
- Indicators and questions for monitoring progress on the 2021 Political Declaration on HIV and AIDS — Global AIDS Monitoring 2023 (2022)
- Lineamientos técnicos de consejería en ITS/VIH (2021)
- Update on the transition to dolutegravir-based antiretroviral therapy (2022)
- Updated Recommendations Onservice Delivery For The Treatment And Care Of People Living With HIV. Summary Slides (2021)
Filter
23
Featured
Recommendations
4
New Publications
7
Language
Document type
Guidelines
12
No document type
10
Studies & Reports
1
Countries / Regions
Malawi
2
Western and Central Europe
2
Kenya
1
El Salvador
1
Authors & Publishers
Publication Years
Category
HIV & STI
11
Policies & Guidelines HIV & TB
2
COVID-19
1
Toolboxes
Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
recommended
2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention,...
The guidelines are aimed at clinical professionals directly involved with and responsible for the care of adults with HIV infection, and at community advocates responsible for promoting the best interests and care of HIV-positive adults. They should be read in conjunction with other published BHIVA ...
The new WHO guidelines recommend that people living with HIV be started on antiretrovirals (ARVs) as soon as possible after being diagnosed. Currently, many people living with the virus globally must wait until their CD4 counts fall to 500 to start treatment. According to the WHO, the move to early ...
